H.R. 9830 aims to maintain the legal commerce of hemp products while ensuring that consumers are protected from synthetic intoxicants that contain high levels of THC. The bill seeks to establish regulations that would allow for the continued sale and distribution of hemp-derived products while addressing safety concerns related to synthetic alternatives.
Supporters of H.R. 9830 have praised the bill for its proactive approach to consumer safety and its commitment to preserving the legal hemp industry. Advocates argue that the legislation will help clarify regulations, promote responsible commerce, and protect consumers from potentially harmful synthetic substances.
Critics of H.R. 9830 have expressed concerns that the bill may inadvertently hinder the growth of the hemp industry by imposing excessive regulations. Some stakeholders fear that the focus on synthetic intoxicants could lead to unnecessary restrictions on legitimate hemp products, potentially stifling innovation and market competition.
The analysis of H.R. 9830, sponsored by Garland Barr, reveals no direct industry overlaps between the bill's subject matter and the sponsor's top donor industries. The primary donor industries include Health Professionals, contributing $160,000,000, and Retired individuals, contributing $50,000,000. Given that the bill focuses on hemp commerce and synthetic intoxicants, which do not directly relate to the interests of health professionals or retired individuals, the potential for conflicts of interest appears minimal. The lack of overlapping interests suggests that the motivations behind the bill are less likely to be influenced by donor interests, leading to a low risk assessment for conflicts of interest. Voters should be aware that while significant sums are involved, the absence of direct connections to the bill's subject matter mitigates concerns about undue influence.
Top industries funding Garland Barr, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
